Table 2.
No OSA vs. OSA | Mild OSA vs. MS OSA | |||||
---|---|---|---|---|---|---|
β | OR (95% CI) | p value | β | OR (95% CI) | p value | |
Age | − 0.02 | 0.98 (0.92–1.05) | 0.60 | − 0.04 | 0.97 (0.88–1.06) | 0.46 |
Gender | − 1.77 | 0.17 (0.04–0.74) | 0.02 | − 0.16 | 0.85 (0.09–7.67) | 0.89 |
Education | − 0.12 | 0.88 (0.73–1.08) | 0.22 | − 0.16 | 0.85 (0.68–1.07) | 0.17 |
Hypertension | 1.53 | 4.61 (1.45–14.69) | 0.01 | 1.18 | 3.25 (0.87–12.14) | 0.08 |
Atrial fibrillation | − 0.11 | 0.90 (0.29–2.78) | 0.85 | 0.17 | 1.18 (0.33–4.27) | 0.80 |
Diabetes | 0.80 | 2.23 (0.68–7.33) | 0.19 | 0.19 | 1.21 (0.35–4.22) | 0.76 |
MI | 0.42 | 1.52 (0.46–5.06) | 0.49 | − 0.75 | 0.47 (0.14–1.6) | 0.23 |
Smoking | 2.22 | 9.18 (2.32–36.28) | 0.00 | − 0.15 | 0.86 (0.11–6.79) | 0.89 |
Drinking | − 0.51 | 0.60 (0.17–2.12) | 0.43 | − 0.55 | 0.57 (0.13–2.56) | 0.47 |
Antiplatelets | 0.22 | 1.25 (0.36–4.35) | 0.73 | − 0.44 | 0.64 (0.17–2.44) | 0.52 |
Anticoagulants | 0.53 | 1.70 (0.38–7.49) | 0.49 | 0.35 | 1.42 (0.33–6.15) | 0.64 |
Statin | 0.52 | 1.68 (0.46–6.1) | 0.43 | 0.11 | 1.11 (0.26–4.8) | 0.89 |
Stroke location | − 0.55 | 0.58 (0.27–1.22) | 0.15 | − 0.27 | 0.76 (0.29–2) | 0.58 |
The associations of clinical variable with the onset of OSA were evaluated by logistic regression. OSA, obstructive sleep apnea; MS OSA, moderate-to-severe OSA; β, partial regression coefficient; OR, odds ratio; 95% CI, 95% confidence interval